JPMORGAN CHASE & CO

Position in CAPR — Capricor Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in CAPR

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$10,445,833

-$207,372 QoQ

Shares Held

343,613

-6.9% QoQ

Ownership

0.593%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 88.13257938436556.ToString("F0")% Shared 0.ToString("F0")% None 11.86742061563445.ToString("F0")%

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,578,690,346 across 405 Biotechnology names. CAPR ranks #71 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	24,150,499	$3,949,089,591
2	REGN	Regeneron Pharmaceuticals, Inc.	4,311,806	$3,331,473,778
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,033,156	$3,140,585,469
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,323,752	$2,092,339,815
5	NUVL	Nuvalent, Inc.	3,088,349	$316,401,351
6	JAZZ	Jazz Pharmaceuticals plc	1,204,353	$227,682,931
7	IONS	Ionis Pharmaceuticals Inc	2,363,567	$177,480,242
8	TERN	Terns Pharmaceuticals, Inc.	2,869,728	$151,292,056

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,445,833	343,613	-6.9%	Shares	Defined	2026-05-13
2025-12-31	$10,653,205	369,134	+94.5%	Shares	Defined	2026-02-11
2025-09-30	$1,368,448	189,799	-2.8%	Shares	Defined	2025-11-26
2025-06-30	$1,938,225	195,189	+1020.2%	Shares	Defined	2025-08-12
2025-03-31	$165,362	17,425	+4.5%	Shares	Defined	2025-05-12
2024-12-31	$230,183	16,680	-70.3%	Shares	Defined	2025-02-12
2024-09-30	$854,785	56,199	+419.5%	Shares	Defined	2024-12-26
2024-06-30	$51,601	10,818	-88.1%	Shares	Defined	2024-12-26
2024-03-31	$618,453	91,083	+118189.6%	Shares	Defined	2024-12-26
2021-06-30	$395	77	-98.6%	Shares	Defined	2021-08-12
2020-09-30	$29,436	5,607	+80000.0%	Shares	Defined	2020-11-12
2020-06-30	$32	7	—	Shares	Defined	2020-08-11
No filing history on record for this holder in this stock.